CoChat
Sign Up
Cited by 118

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Role of microRNA-155 in autoimmunity

Leng, Rui-Xue, Pan, Hai-Feng, Qin, Wei-Zi, Chen, Gui-Mei, Ye, Dong-Qing·2011·Cytokine & Growth Factor Reviews
DOI 10.1016/j.cytogfr.2011.05.002
Open this paper in CoChat — free account

Abstract

MicroRNAs (miRNAs) have recently emerged as a major class of gene expression regulators linked to most biological functions. MiR-155 is encoded within a region known as B cell integration cluster (Bic) gene, identified originally as a frequent integration site for the avian leukosis virus. Disregulation of endogenous miR-155 has been implicated in the pathogenesis of human cancers. Recently, aberrant expression of miR-155 was observed in many autoimmune conditions, including rheumatoid arthritis (RA), multiple sclerosis (MS), and systemic lupus erythematosus (SLE). Moreover, functional analysis demonstrated that miR-155 has powerful regulatory potential in a wide variety of immune cells through targeting specific mRNAs. Since pathogenic immune cells play a pivotal role in pathogenesis of human autoimmune diseases, miR-155 might be a versatile therapeutic target. This review will discuss the current understandings for the role of miR-155 in autoimmunity.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.cytogfr.2011.05.002

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 58

  1. Miska, 2005, How microRNAs control cell division, differentiation and death, Curr Opin Genet Dev, 15, 563, 10.1016/j.gde.2005.08.005 · DOI
  2. Park, 2008, MicroRNAs and death receptors, Cytokine Growth Factor Rev, 19, 303, 10.1016/j.cytogfr.2008.04.011 · DOI
  3. Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
  4. Miranda, 2006, A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes, Cell, 126, 1203, 10.1016/j.cell.2006.07.031 · DOI · Paper page
  5. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  6. Alevizos, 2010, MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease, Autoimmun Rev, 9, 618, 10.1016/j.autrev.2010.05.009 · DOI
  7. Chua, 2009, MicroRNAs: biogenesis, function and applications, Curr Opin Mol Ther, 11, 189
  8. Yang, 2005, MicroRNAs: small regulators with a big impact, Cytokine Growth Factor Rev, 16, 387, 10.1016/j.cytogfr.2005.02.008 · DOI
  9. Eulalio, 2008, Getting to the root of miRNA-mediated gene silencing, Cell, 132, 9, 10.1016/j.cell.2007.12.024 · DOI
  10. Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 · DOI · Paper page
  11. Li, 2007, miR-181a is an intrinsic modulator of T cell sensitivity and selection, Cell, 129, 147, 10.1016/j.cell.2007.03.008 · DOI
  12. Lu, 2010, Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses, Cell, 142, 914, 10.1016/j.cell.2010.08.012 · DOI · Paper page
  13. Iborra, 2010, MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response, Autoimmun Rev, 10.1016/j.autrev.2010.07.002 · DOI
  14. Calame, 2007, MicroRNA-155 function in B Cells, Immunity, 27, 825, 10.1016/j.immuni.2007.11.010 · DOI
  15. O’Connell, 2010, MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development, Immunity, 33, 607, 10.1016/j.immuni.2010.09.009 · DOI · Paper page
  16. Zhou, 2010, miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells, Blood, 116, 5885, 10.1182/blood-2010-04-280156 · DOI · Paper page
  17. Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI
  18. Wang, 2010, Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus, J Rheumatol, 37, 2516, 10.3899/jrheum.100308 · DOI
  19. Junker, 2009, MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47, Brain, 132, 3342, 10.1093/brain/awp300 · DOI · Paper page
  20. Tam, 1997, bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA, Mol Cell Biol, 17, 1490, 10.1128/MCB.17.3.1490 · DOI
  21. Lagos-Quintana, 2002, Identification of tissue-specific microRNAs from mouse, Curr Biol, 12, 735, 10.1016/S0960-9822(02)00809-6 · DOI · Paper page
  22. Tam, 2001, Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA, Gene, 274, 157, 10.1016/S0378-1119(01)00612-6 · DOI
  23. van den Berg, 2003, High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma, Genes Chromosomes Cancer, 37, 20, 10.1002/gcc.10186 · DOI
  24. Kluiver, 2005, BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas, J Pathol, 207, 243, 10.1002/path.1825 · DOI
  25. Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc Natl Acad Sci USA, 103, 7024, 10.1073/pnas.0602266103 · DOI
  26. Metzler, 2004, High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma, Genes Chromosomes Cancer, 39, 167, 10.1002/gcc.10316 · DOI
  27. Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI
  28. Vigorito, 2007, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells, Immunity, 27, 847, 10.1016/j.immuni.2007.10.009 · DOI
  29. Teng, 2008, MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase, Immunity, 28, 621, 10.1016/j.immuni.2008.03.015 · DOI
  30. Liu, 1998, The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling, J Exp Med, 188, 1333, 10.1084/jem.188.7.1333 · DOI
  31. Leung, 2009, Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes, Immunol Res, 43, 243, 10.1007/s12026-008-8078-1 · DOI
  32. Helgason, 2000, A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship −/− mice, J Exp Med, 191, 781, 10.1084/jem.191.5.781 · DOI
  33. O’Connell, 2009, Inositol phosphatase SHIP1 is a primary target of miR-155, Proc Natl Acad Sci USA, 106, 7113, 10.1073/pnas.0902636106 · DOI · Paper page
  34. Pedersen, 2009, Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas, EMBO Mol Med, 1, 288, 10.1002/emmm.200900028 · DOI
  35. Blüml, 2011, Essential role for micro-RNA 155 in the pathogenesis of autoimmune arthritis, Arthritis Rheum, 10.1002/art.30281 · DOI
  36. Banerjee, 2010, Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells, Eur J Immunol, 40, 225, 10.1002/eji.200939381 · DOI
  37. Tarasenko, 2007, T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses, Proc Natl Acad Sci USA, 104, 11382, 10.1073/pnas.0704853104 · DOI
  38. Leng, 2011, The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus, Autoimmun Rev, 10.1016/j.autrev.2011.01.007 · DOI
  39. Pan, 2011, Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?, Lupus, 20, 227, 10.1177/0961203310389842 · DOI
  40. Du, 2009, MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis, Nat Immunol, 10, 1252, 10.1038/ni.1798 · DOI · Paper page
  41. Zhu, 2011, Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration, Atherosclerosis, 10.1016/j.atherosclerosis.2010.12.024 · DOI
  42. Kohlhaas, 2009, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J Immunol, 182, 2578, 10.4049/jimmunol.0803162 · DOI
  43. Lu, 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein, Immunity, 30, 80, 10.1016/j.immuni.2008.11.010 · DOI
  44. Bayer, 2007, Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells, J Immunol, 178, 4062, 10.4049/jimmunol.178.7.4062 · DOI
  45. Stahl, 2009, miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression, PLoS One, 4, e7158, 10.1371/journal.pone.0007158 · DOI
  46. Divekar, 2011, Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu, J Immunol, 186, 924, 10.4049/jimmunol.1002218 · DOI
  47. Ceppi, 2009, MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells, Proc Natl Acad Sci USA, 106, 2735, 10.1073/pnas.0811073106 · DOI · Paper page
  48. Lu, 2011, MiR-221 and miR-155 regulate human dendritic cell development, apoptosis and IL-12 production through targeting of p27kip1, KPC1 and SOCS-1, Blood, 10.1182/blood-2010-12-322503 · DOI
  49. Murata, 2010, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, 12, R86, 10.1186/ar3013 · DOI
  50. Pauley, 2008, Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res Ther, 10, R101, 10.1186/ar2493 · DOI
  51. Niimoto, 2010, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, 11, 209, 10.1186/1471-2474-11-209 · DOI
  52. Dai, 2010, Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus, PLoS One, 5, e14302, 10.1371/journal.pone.0014302 · DOI
  53. Takagi, 2010, Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis, J Gastroenterol Hepatol, 25, S129, 10.1111/j.1440-1746.2009.06216.x · DOI
  54. O’Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc Natl Acad Sci USA, 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
  55. Yin, 2008, B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element, J Biol Chem, 283, 2654, 10.1074/jbc.M708218200 · DOI
  56. McCoy, 2010, IL-10 inhibits miR-155 induction by toll-like receptors, J Biol Chem, 285, 20492, 10.1074/jbc.M110.102111 · DOI
  57. Park, 1998, Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus, Clin Exp Rheumatol, 16, 283
  58. Nath, 2005, Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis, Hum Genet, 118, 225, 10.1007/s00439-005-0044-6 · DOI

Cited by

Sorted by citations

Metadata

Authors
Leng, R.-X., Pan, H.-F., Qin, W.-Z., Chen, G.-M., & Ye, D.-Q.
Venue
Cytokine & Growth Factor Reviews
Publisher
Elsevier BV
Published
2011-06
Volume
22
Issue
3
Pages
141-147
ISSN
1359-6101
DOI
10.1016/j.cytogfr.2011.05.002
Cited by
118
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review